GISSI-HF was a 3.9 years prospective, multi-center, double-blind, placebo-controlled study of 6,975 patients at. A dose of 1 g daily, reduced n – 3 PUFA all-cause mortality by 9 percent and for the combination of all-cause mortality and hospital admissions for cardiovascular reasons by 8 percent ).
Researchers in this study, however, show that these systems are not capable of a Darwinian evolution. For the first time a rigorous analysis was performed to investigate the alleged evolution of these molecular networks using a combination of numerical and analytical simulations and network analysis approximations. Their research shows that the dynamics of the molecular compound populations evolve after reaching a critical size to not split, as to lose during this process , the compounds properties that are important for the Darwinian evolution.Continue Reading